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ABSTRACT
Ribosome biogenesis is a complex process orches-
trated by a host of ribosome assembly factors. Al-
though it is known that many of the proteins involved
in this process have RNA binding activity, the full
repertoire of proteins that interact with the precur-
sor ribosomal RNA is currently unknown. To gain a
greater understanding of the extent to which RNA-
protein interactions have the potential to control ri-
bosome biogenesis, we used RNA affinity isolation
coupled with proteomics to measure the changes in
RNA-protein interactions that occur when rRNA tran-
scription is blocked. Our analysis identified 211 out
of 457 nuclear RNA binding proteins with a >3-fold
decrease in RNA-protein interaction after inhibition
of RNA polymerase I (RNAPI). We have designated
these 211 RNA binding proteins as the RNAPI RNA
interactome. As expected, the RNAPI RNA interac-
tome is highly enriched for nucleolar proteins and
proteins associated with ribosome biogenesis. Se-
lected proteins from the interactome were shown to
be nucleolar in location and to have RNA binding
activity that was dependent on RNAPI activity. Fur-
thermore, our data show that two proteins, which are
required for rRNA maturation, AATF and NGDN, and
which form part of the RNA interactome, both lack
canonical RNA binding domains and yet are novel
pre-rRNA binding proteins.
INTRODUCTION
The ribosome is a complex macromolecular machine, com-
posed of ribosomal RNA (rRNA) and ribosomal proteins,
which translates the genetic code into functional polypep-
tides. Ribosome biogenesis commenceswith the synthesis of
a large precursor rRNA (pre-rRNA) by RNA polymerase
I (RNAPI). Processing of the pre-rRNA through cleavage
and trimming events leads to the production of mature
28S, 18S and 5.8S rRNA. Ribosomal proteins are precisely
guided on to the folding rRNA to form the pre-40S and
pre-60S ribosomal subunits (1). Overall, ribosome biogen-
esis is a highly coordinated process that requires numerous
conserved assembly factors. Thus, in yeast, ∼350 assembly
factors have been identified, whereas in mammalian cells,
>500 proteins that affect ribosome biogenesis have been de-
scribed (2,3). Many of these mammalian ribosome biogen-
esis factors are RNA binding proteins (RBPs). Indeed, re-
cent RNA interactome studies suggest that∼70% of the 286
proteins that influence rRNA processing may interact with
RNA (2). This finding is unsurprising given that the pre-
rRNAmust be cleaved, digested,modified, and dynamically
remodelled to create a functional ribosome. However, it has
not been defined which of these potential ribosome biogen-
esis RBPs contact the rRNA directly and how many have a
more indirect role in ribosome biogenesis.
With the advent of RNA interactome capture (RIC) it
has emerged that RNA binding proteins are considerably
more prevalent than was previously realised (4). One recent
estimate suggests that there are nearly 1400 potential RBPs
in the human genome (5,6). A substantial number of these
RBPs lack classical RNA binding domains and many have
no obvious link to RNA biology (5,6). Rather surprisingly,
despite the fact that RIC relies on the capture of polyadeny-
lated RNA, a considerable proportion of these RBPs have
known roles in ribosome biogenesis or links to nucleolar
function. Our data show that RIC also isolates significant
quantities of pre-rRNA through RNA-RNA contacts with
the mRNA. Therefore, we used this property to charac-
terise those RBPs that directly contact the pre-rRNA or
other RNAPI transcripts. We identified 211 potential RBPs
that displayed reduced RNA association after RNAPI inhi-
bition, which we designate the RNAPI RNA interactome.
Importantly, these RBPs were highly enriched for nucleo-
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lar resident proteins and proteins with a known role or pro-
posed role in ribosome biogenesis. Selected proteins from
our RNAPI RNA interactome were shown to interact with
RNA and these interactions were diminished after RNAPI
inhibition. Finally, we extended our study by providing ev-
idence that proteins from the previously identified ANN
complex (7), comprised of AATF, neuroguidin (NGDN)
and NOL10, and which functions in ribosome biogenesis,
are novel pre-rRNA binding proteins.
MATERIALS AND METHODS
Cell culture, constructs and stable cell lines
U-2 OS and MCF10A cells were grown at 37◦C with
5% CO2. U-2 OS were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% FBS
and MCF10A in DMEM/F12 Ham’s Mixture supple-
mented with 5% horse serum, 10 g/ml insulin (Sigma-
Aldrich), 100 ng/ml cholera toxin (Sigma-Aldrich), 20
ng/ml EGF (Peprotech) and 0.5 mg/ml hydrocortisone
(Sigma-Aldrich). MCF10A and U-2 OS cells were treated
with 10 nM actinomycin D (Sigma-Aldrich) or 2.5 M
CX5461 (Selleckchem).
The U-2 OS Flp-In T-REx cell line was generated us-
ing the manufacturer’s recommended protocol (Thermo
Fisher Scientific). The coding regions of AATF, NGDN
and TAP26 were inserted in frame with the N-terminal
3xFLAG tag in pCDNA5/FRT/TO (Thermo Fisher Sci-
entific). Constructs were then transfected into the U-2 OS
Flp-In T-REx cell line and stable clones were selected with
100 g/ml hygromycin B (Invitrogen) and 2.5 g/ml blas-
ticidin (Corning).
Western analysis, immunoprecipitation and RNA immuno-
precipitation (RIP)
For western analysis, proteins were separated on 4–12%
SDS PAGE gel (Thermo Fisher Scientific), transferred on
to PVDF membrane (Bio-Rad) and detected with the indi-
cated antibodies (Supplementary Table S1).
To prepare nuclei, U-2 OS cells were incubated in CLB
buffer (10 mM HEPES pH 7.5, 10 mM NaCl, 3 mM
MgCl2, 0.35 M sucrose, 0.5% NP-40) with protease in-
hibitors (cOmplete, Roche) for 5 min on ice and then cen-
trifuged at 1300g for 5 min at 4◦C. The nuclear pellet was
washed twice with CLB and incubated for 30 min in SNEB
buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 1% NP40,
0.5% deoxycholate, 0.1% SDS) with protease inhibitors,
with or without 0.2 U/ml Benzonase (Novagen), as indi-
cated. The extract was then cleared by centrifugation.
For standard immunoprecipitations, protein G Dyn-
abeads (Thermo Fisher Scientific) were incubated for 30
min with 3 g of specific antibody (Supplementary Table
S1) or rabbit/mouse IgG in TBS. After extensive wash-
ing, the antibody-bead conjugates were incubated with pro-
tein extract for 2 h at 4◦C. Proteins were eluted with either
2xSDS PAGE loading buffer or, for FLAG immunoprecip-
itations, proteins were eluted with 3 ng/l FLAG peptide
(Sigma-Aldrich).
For RNA immunoprecipitations (RIP), U-2 OS cells
were cross-linked with 0.2% formaldehyde for 8 min, incu-
bated in neutralisation buffer (2.5 M glycine and 25 mM
Tris pH 7.4) for 5 min and washed twice in PBS. Nuclear
extraction and immunoprecipitation were conducted as de-
scribed above with the following modifications. The beads
were washed twice in 20 mM HEPES pH 7.5, 350 mM
NaCl, 1% NP40, 0.5% deoxycholate, 0.25% SDS, 5 mM
DTT for 3 min and twice with 20 mM Tris pH 7.4, 150
mM NaCl, 0.1% NP-40 for 5 min. Finally, the beads were
treated with proteinase K (Thermo Fisher Scientific) and
Turbo DNase (Ambion). Purified RNA was used for RT-
qPCR analysis.
RT-qPCR
Reverse transcription was performed with random primers
(Invitrogen) and Superscript™ II (Thermo Fisher Scientific)
according to the manufacturer’s instructions with 5 l of
purified RIP RNA or 300 ng of total RNA. The qPCR was
performed using SensiFAST™ Sybr Lo-Rox Mix kit (Bio-
line) with specific primers to amplify sequences (Supple-
mentary Table S1).
RNA interactome capture (RIC)
RIC was performed on nuclear extracts of MCF10A and
U-2 OS. Briefly, cells were treated with 10 nM actinomycin
D, 2.5 MCX5461 or DMSO. Cells were washed with cold
PBS, and cross-linked with UVC (150 mJ/cm2) irradiation.
Nuclei were isolated as described above and were resus-
pended in oligo(dT) binding buffer (20 mMTris pH7.4, 500
mM LiCl, 0.5% LiDS, 1 mM EDTA, 5 mM DTT). Nu-
clear lysate was incubated with magnetic oligo(dT) beads
(NEB) for one hour at room temperature. Subsequently, the
beads were washed and the RNAwas eluted from the beads
(4). The eluted RNAwas supplemented with 2 mMMgCl2,
125U Benzonase (Sigma-Aldrich) and 300U RNase I (Am-
bion) to digest the RNA.
Quantitative mass spectrometry
LC–MS/MS was used to identify and quantify RNA bind-
ing proteins (RBPs) as described previously (8). Briefly, UV-
crosslinked RBPs were separated by SDS PAGE and serial
gel slices digested in situ with trypsin (9). Extracted tryptic
peptides were analysed using data-independent acquisition
(DIA) on a nanoAcquityUPLC system coupled to aWaters
Synapt G2-S HDMS mass spectrometer. The PLGS ‘TOP
3’ method was used for absolute quantification of proteins
(10).
Immunolocalization
U-2 OS cells were seeded on to glass coverslips and after
the indicated treatments were fixed in 4% paraformalde-
hyde. Primary antibody incubations were performed at 4◦C
overnight with the indicated antibodies (Supplementary Ta-
ble S1). Secondary fluorescent antibodies were incubated
for 1 h at room temperature (Supplementary Table S1). Fi-
nally, the nuclei were labelled with Hoechst 33342 (Thermo
Fisher Scientific). Images were acquired on Zeiss 510 con-
focal microscope and analysed with ImageJ.
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Bio-informatic analysis
Protein/Gene IDs across different datasets were unified
to Uniprot IDs or Gene Symbols using the ‘queryMany’
function in the ‘mygene’ package available through Bio-
conductor (http://bioconductor.org/packages/release/bioc/
html/mygene.html). We assessed our dataset using Gene
Ontology, InterPro domain and KEGG pathway annota-
tions all accessed via the ‘mygene’ package (11,12). Anal-
yses were performed using the R statistical framework us-
ing the Bioconductor packages goseq, mygene, clusterPro-
filer and their dependencies (11). ClusterProfiler code was
modified to generate easy to interpret visualisation and out-
put tables complete with the genes in each enriched cate-
gory. The background list used in these analyses was de-
rived from the MCF10A proteome (Dezi, unpublished).
Themaximum expression of each protein (across replicates)
was used as bias during enrichment analyses performed us-
ing goseq (13,14). Only those proteins present in the back-
ground list are represented in functional enrichment analy-
ses. Hence, there are 457 proteins in our interactome, but
only 402 of them are represented in the MCF10A back-
ground and have GO terms associated with them. Code
used in this study and supplementary data can be accessed
via Bitbucket using this link https://bitbucket.org/emm13/
2018 pineiro nucleolarrbp/src.
RESULTS
Identification of RNAPI-dependent RNA binding proteins
RNA interactome analysis is a technique that was origi-
nally designed to isolate mRNA binding proteins (15,16).
First, cells are irradiated with ultraviolet light to covalently
couple proteins and any RNA in contact with these pro-
teins in vivo. Cells are lysed under denaturing conditions,
and polyadenylated mRNA and their associated proteins
are then isolated using oligo(dT) affinity chromatography.
This isolation process allows for the use of highly stringent
wash conditions to remove any non-covalently bound pro-
teins. Consequently, after nuclease digestion to remove the
RNA, the sample is highly enriched for proteins that inter-
act with mRNA (17). Recent advances in mass spectrome-
try have allowed the identification of ‘poly(A) RNA bind-
ing proteins’ from several different organisms and cell-types
and these studies have vastly expanded the repertoire of po-
tential RBPs (6).
In preliminary experiments using RIC, we noted that the
RNA that was isolated using this technique contained a sig-
nificant quantity of both pre-ribosomal RNA and mature
rRNA (Supplementary Figure S1 and Figure 1C). Since the
buffer conditions in the RIC protocol (0.5% LiDS, 0.5%
LiCl) favour nucleic acid hybridization, we reasoned that
rRNA was purified as a consequence of interactions be-
tween the mRNA and the abundant rRNA (Figure 1A).
Disruption of these RNA-RNA interactions using heat
coupled with two rounds of oligo(dT) purification, as used
in the original RIC protocol from the Dreyfuss lab (18), re-
sulted in almost complete loss of rRNA species from the
RIC RNA, but the majority of the mRNA was retained
(Supplementary Figure S1B).Moreover, we show that prior
depletion of poly(A) RNAs from the lysate results in com-
plete loss of rRNA species in the RIC RNA (Supplemen-
tary Figure S1C). Thus, these data suggest that the more re-
cently developed RIC protocol, which uses only one round
of oligo(dT) purification and no denaturation of the RNA
(17), has the potential to identify not only mRNA binding
proteins, but also rRNA binding proteins (Figure 1A).
Since an RNA interactome contains pre-ribosomal RNA
(Supplementary Figure S1; Figure 1C), we reasoned that we
could identify RBPs involved in ribosome biogenesis by an-
alyzing changes in the RNA interactome that occur after
in vivo pre-rRNA depletion through inhibition of RNAPI.
We focussed on the nuclear RNA interactome to minimize
the potential for RNA-protein interactions in the mature
ribosome masking any changes that are due to the loss of
pre-rRNA and we used a low concentration of actinomycin
D (ActD) to preferentially inhibit rRNA transcription (19).
Thus MCF10A cells were exposed to ActD at a concentra-
tion that was sufficient to inhibit the activity of RNAPI,
but with minimal effect on RNA polymerase II (RNAPII)
transcription. Three hours after exposure to 10 nM ActD,
we confirmed that there was a substantial decrease in to-
tal RNA transcription (Figure 1B). Furthermore, northern
analysis of RIC RNA revealed that there was a large de-
crease in the abundance of the 45S, 32S, 30S and 12S pre-
rRNA in the captured RNA, indicating that rRNA tran-
scription was inhibited under these conditions and that
most of the existing intermediates are processed during this
time (Figure 1C). However, ActD had little or no effect on
the synthesis of polyadenylated RNA and therefore at this
concentration the drug has little effect on RNAPII tran-
scription (Figure 1B). Subsequently, RBPs were isolated by
RIC from control and ActD treated cells. The spectrum of
recovered RBPs was altered considerably after RNAPI in-
hibition, suggesting that many RBPs recovered by RIC in-
teract with RNAPI RNA (Figure 1D). Examination of the
recovered RBPs by western analysis revealed that, as we
predicted, the association of the known pre-rRNA binding
proteins, nucleolin (NCL) and nucleophosmin (NPM) with
RNA, was considerably reduced after RNAPI inhibition.
However, the recovery of the mRNA binding proteins PTB
and HuR was unchanged under these conditions (Figure
1E). These observations strongly suggested that ourmethod
selectively depletes RNAPI RNA and its associated RBPs
and therefore this approach could be used to characterise
the RNAPI RNA interactome.
RBPs were isolated from control and ActD treated cells
followed by quantitative label-free mass spectrometry to
reveal RNA binding interactions that are dependent on
RNAPI activity. We identified 457 potential RNA binding
proteins in the nuclear proteome ofMCF10A cells (Supple-
mentary Table S2). Of these proteins, 211 showed reduced
binding (3-fold or more; ActD/Ctrl ratio ≤ 0.35) follow-
ing treatment with ActD and we classified these as RNAPI-
dependent RBPs (RNAPI-dep; Figure 1F). Those proteins
that do not show a significant change after RNAPI inhibi-
tion (246/457) were labelled as RNAPI-independent RBPs
(RNAPI-indep; Figure 1F, Supplementary Table S2).
Analyses of these data showed that 384 of 402 pro-
teins with Gene Ontology (GO) terms (95%) are function-
ally annotated as RNA binding (Supplementary Table S3:
‘GO:0003723’). As expected, many of the RBPs identified
Nucleic Acids Research, 2018, Vol. 46, No. 20 11005
Figure 1. RNA interactome capture to identify RBPs that interact with RNA transcribed by RNAPI. (A) Schematic to show the process of RNA inter-
actome capture and how rRNA binding proteins are identified by RIC. (B) A low concentration of actinomycin D inhibits total RNA synthesis without
affecting mRNA synthesis. Cells were incubated with media containing [3H]-uridine and total RNA or polyadenylated mRNA was isolated. After nor-
malising to the amount of RNA, the radioactivity incorporated into the two fractions was taken as a measure of RNA synthesis. Black bars are control
samples and white bars are ActD-treated samples. (C) RNA isolated by RIC contains substantial amount of rRNA species. RIC was performed and the
resulting RNAwas analysed by northern analysis (35). Lane 1, `T” denotes total cellular RNA (nucleus and cytoplasm), lanes 2–5 are RIC RNA prepared
from the nuclear RNA fraction. Methylene blue staining shows significant quantities of mature rRNA and pre-rRNA in the RIC RNA. The 28S and
18S pre-rRNA intermediates were detected using radiolabelled oligonucleotides to ITS1 and ITS2 (35). Treatment of the cells with 10 nM actinomycin D
results in a time-dependent loss of pre-rRNA from the RIC RNA. (D) RNA interactome capture was performed on control and actinomycin D-treated
MCF10A cells. The resulting proteins were separated by SDS PAGE and visualised using silver staining. (E) RIC was performed as in (D) and the RNA
binding proteins nucleolin (NCL), nucleophosmin (NPM), polypyrimidine tract binding protein (PTB) and ELAV-like protein 1 (HuR) were detected us-
ing western analysis. The RBPs can be detected only after UV cross-linking. Actinomycin D treatment significantly reduces the recovery of the pre-rRNA
binding proteins NCL and NPM, but has no effect on the mRNA binding proteins PTB and HuR. Histone H3 (H3) was used as a non-RNA binding
control. (F) Mass spectrometry analysis identified 457 RBP candidates. The figure shows the distribution of the ratio of protein abundance between ActD
treated and control cells. The density curve (blue) outlines the trend of the distribution showing two peaks at 0 (complete loss after ActD treatment) and
at 0.9 (very little loss after ActD treatment). The superimposed shading under the density curve shows the cut-off used to determine RNAPI-dependent
(gold, ratio ≤ 0.35) and RNAPI-independent (gray, ratio > 0.35) proteins.
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contain canonicalRNAbinding domains such asRRMand
KH domains (Figure 2A) and interestingly, a significantly
higher proportion of RNAPI-independent RBPs contain-
ing the RRM domain relative to their RNAPI-dependent
counterparts (Figure 2A; P value = 1.562e–15). Further-
more, a comparison of the MCF10A RNA interactome
capture data with those from three other cell lines (17,20)
showed that 90% (409/457) of these candidate RBPs have
been identified previously using RIC (Figure 2B). A sub-
stantial number of the remaining 10% (48/457) also have
RNA binding functions (red circles, Supplementary Fig-
ure S2A). In conjunction, these analyses confirm that our
method has delivered a high confidence set of RNA bind-
ing proteins.
Functional analysis supports RNAPI-dependent RBPs as nu-
cleolar resident proteins.
We predicted that the majority of nuclear RBPs that have
decreased RNA binding upon RNAPI inhibition are lo-
cated in the nucleolus. Using GO annotations, 193 of the
457 nuclear RBPs are known to be resident in the nucleolus
(‘GO:0005730’) of which 75% (144) are RNAPI-dependent
(Supplementary Table S2). In addition, 56% (257/457) of
the nuclear RBPs identified in this study were present in
the nucleolar proteome characterised by Andersen et al.
(21) with 79% (166/211) of the RNAPI-dependent and 37%
(91/246) of the RNAPI-independent RBPs described as nu-
cleolar (Figure 2C, Supplementary Tables S4 and S5). To
gain further support for the nucleolar localisation of the
RNAPI-dependent RBPs, we searched for the presence of
nucleolar localisation signals (NoLS; (22)) and nucleolar
detention signals (NoDS; (23)). Our data showed no differ-
ence between NoDs in the RNAPI-dependent versus inde-
pendent RBPs. However, there was a significant difference
in the distribution of NoLS, with more NoLS decorating
RNAPI-dependent proteins thanRNAPI-independent pro-
teins (Supplementary Figure S2B). Taken together these ob-
servations support the nucleolar localisation of theRNAPI-
dependent RBPs.
To gain insight into the function of the nuclear RBPs,
we performed enrichment analyses using Kyoto Encyclo-
pedia of Gene and Genomes (KEGG) pathways and GO
terms (Figure 2D and E; Supplementary Table S3 and
S6). KEGG pathway analysis revealed that the RNAPI-
dependent RBPs are enriched for proteins involved in ri-
bosome biogenesis, whereas the RNAPI-independent RBPs
play a role in splicing, mRNA surveillance and RNA trans-
port (Figure 2D). When GO enrichment was applied to the
RNAPI-dependent proteins, the terms identified are rRNA
processing (GO:0006364), maturation of SSU-rRNA from
tricistronic rRNA transcript (GO:0000462) and ribosomal
large subunit biogenesis (GO:0042273) with gene products
associated with the nucleolus, the small subunit processome
and the large subunit pre-ribosome (Figure 2E; Supplemen-
tary Table S6). In addition, 44% (92/211) of the RNAPI-
dependent RBPs were also identified as playing a role in
ribosomal RNA processing in a large scale siRNA screen
(2), whereas, only 10% (27/246) of the RNAPI-independent
RBPs scored positive in this screen (Figure 2C). Thus, the
RNAPI-dependent RBPs are highly enriched for ribosome
biogenesis functions. In contrast, the biological processes
associated with the RNAPI-independent RBPs are mRNA
splicing (GO:000398), mRNA processing (GO:006397) and
the regulation of alternative splicing (GO:000381) (Figure
2E).
We chose to investigate further RNAPI-dependent RBPs
that have no canonical RNA binding domains and have
a poorly characterised role in ribosome biogenesis (Figure
2F). Thus, AATF, NOL10 and NGDN are part of the re-
cently described ANN complex that may play a role in pre-
rRNA cleavage (7). TAP26 and IFI16 were previously iden-
tified as potential ribosome biogenesis factors (2). Finally,
the Ku proteins (KU70/80) are known to be nucleolar and
interact with the telomerase RNA (hTR) (24,25), but they
have never been defined as ribosome biogenesis factors. All
of these candidate RNAPI-dependent RBPs were identified
in previous RNA interactome analyses, supporting our ob-
servations that they contact RNA. Nevertheless, there is no
direct evidence that any of these proteins interact with pre-
rRNA.
RNAPI-dependent RBPs accumulate in the nucleolus
In the first instance, we analysed the subcellular distribu-
tion of our chosen proteins to confirm that they accumulate
in the nucleolus. For immunolocalisation of AATF, KU70,
NOL10 and IFI16, we used antibodies to the endogenous
proteins. Commercial antibodies of sufficient quality were
not available for immunolocalisation of NGDN or TAP26
and therefore we generated stable inducible cell lines ex-
pressing epitope tagged proteins using the Flp-In T-REx
system (Supplementary Figure S3). All of our subsequent
experiments were performed in U-2 OS cells since we en-
countered problems establishing a stable Flp-In MCF10A
cell line. We felt justified in doing so because ribosome
biogenesis is an extremely well conserved process and U-2
OS are a common model cell line to study nucleolar func-
tions. In addition, large-scale protein localisation data are
available for these cells as part of the Human Atlas pro-
tein project (26). We also investigated the role of RNAPI
transcription on the nucleolar retention of the RNAPI-
dependent RBPs using the RNAPI inhibitors ActD and
CX5461. CX5461 is a selective inhibitor ofRNAPI that pre-
vents the polymerase from loading on to the rDNA pro-
moter (27,28). We used ActD and CX5461 at concentra-
tions that substantially inhibited rRNA synthesis, but had
no effect on mRNA synthesis. U-2 OS cells were treated
with either CX5461 or ActD and rRNA transcription was
measured using RT-qPCR analysis of precursor rRNA that
contain the 5′ETS. Treatment of cells with CX5461 or
10 nM ActD substantially inhibited rRNA transcription,
whereas the abundance of the short-lived c-mycmRNAwas
unaltered by these treatments (Supplementary Figure S4).
In unperturbed cells, the majority of AATF, TAP26,
NOL10, IFI16 andNGDNwas found in the nucleolus (Fig-
ure 3A–E). In contrast, as reported previously (24), KU70
was found predominantly in the nucleoplasm with some
accumulation in the nucleolus (Figure 3F). After inhibi-
tion of RNAPI transcription with ActD or CX5461, KU70
staining was no longer found in the nucleolus, suggesting
that RNAPI activity facilitates the retention of KU70 in
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Figure 2. Bio-informatic analysis of the MCF10A RNA interactome. (A) All proteins in the RNAPI-dependent and independent lists were mapped to
Interpro domains (https://www.ebi.ac.uk/interpro/). A barplot was generated showing the distribution of the most frequently occurring (in 5 or more
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the nucleolus (Figure 3F). A significant quantity of TAP26,
IFI16 and NGDN was also released from the nucleolus af-
ter RNAPI inhibition (Figure 3B, D, E). However, ActD
and CX5461 had little or no effect on the nucleolar locali-
sation of NOL10 or AATF (Figure 3A and C). We specu-
late that in the case of proteins that remain associated with
the nucleolus following RNAPI inhibition such as AATF
and NGDN, both RNA-protein and protein-protein inter-
actions are required for tethering in this organelle. How-
ever, proteins that are located in the nucleolus solely due
to rRNA binding (e.g. IFI16 and KU70) are released fol-
lowing exposure to cell stresses that inhibit RNAPI allow-
ing their relocation into the cytoplasm/nucleoplasm, where
they may have alternative functions. Thus, all of our can-
didate RNAPI-dependent RBPs have a nucleolar presence,
but the extent to which nucleolar accumulation depends on
RNAPI transcription varies between proteins.
The interaction of AATF, NOL10, NGDN, IFI16, TAP26,
KU70 and KU80 with RNA is disrupted following inhibition
of RNAPI
To validate the RNAPI RNA interactome, we inhibited
RNAPI activity using ActD or CX5461 and performed
RNA interactome capture followed by western analysis for
our proteins of interest. Nucleolin (NCL) or nucleophos-
min (NPM), which are RBPs with well-described roles in
ribosome biogenesis, were used as positive controls, and
the mRNA binding protein, PTB, was used as a negative
control. After inhibition of RNAPI, there was a consider-
able reduction in the recovery of AATF, NOL10, NGDN,
TAP26 and IFI16 in the RIC samples and a more mod-
est reduction in the recovery of the Ku proteins (Figure
4). The magnitude of the changes is in complete agreement
with our mass spectrometry experiments (Figure 2F). The
pre-rRNA binding proteins NCL and NPM also show de-
creased recovery in these experiments, whereas the recov-
ery of mRNA binding protein PTB is unchanged. Taken to-
gether these data suggest that our candidate proteins inter-
act with RNAPI RNA. For AATF, NOL10, NGDN, IFI16
and TAP26, inhibition of rRNA synthesis has a substantial
impact on the recovery of these proteins by RIC, suggest-
ing that the major RNA species that these proteins interact
with in this assay is derived from RNAPI (Figure 3A–D).
However, the partial inhibition of Ku protein RNA binding
after RNAPI inhibition (Figure 3E and F) most likely re-
flects the interaction of these proteins with other classes of
RNA, in addition to RNAPI transcripts (29,30).
AATF and NGDN are novel pre-rRNA binding proteins
To provide direct evidence for the interaction of proteins
identified in our RNAPI interactome with ribosomal RNA
we chose to study AATF and NGDN in further detail. It
has been suggested that these proteins in combination with
NOL10 form a complex, the ANN complex, that plays a
role in 18S rRNA maturation by facilitating endonucle-
olytic cleavage within the 5′ETS and ITS1 (7). Our RNA
interactome data confirms that all three proteins contact
RNA derived from RNAPI, despite the lack of a recog-
nizable RNA binding domain in any of the three proteins.
Clearly, themajorRNAPI transcript in the cell is pre-rRNA
and therefore, we tested the hypothesis that the members of
the ANN complex are novel pre-rRNA binding proteins.
Initially, we attempted to confirm the previously pub-
lished interaction between these three proteins (7). When
endogenous AATF was immuno-affinity isolated from U-
2 OS cells, we found that significant quantities of NOL10
and NGDN co-purified with this protein, suggesting that
the three proteins are present in a complex (Figure 5A).
Interestingly, only NOL10 co-purified with AATF when
AATF was immuno-affinity purified from nuclease-treated
extracts (Figure 5A). The release of NGDN from the
complex following nuclease treatment implies that NOL10
and AATF interact through protein-protein interactions,
whereas NGDN is co-purified with AATF and NOL10
through RNA–protein interactions.
To probe the interaction of AATF and NGDN with pre-
rRNA, we took a cross-linking immunoprecipitation ap-
proach. Thus, RNA-protein complexes were cross-linked in
vivo using a short exposure to a relatively low concentra-
tion of formaldehyde. Subsequently, immuno-affinity isola-
tionwas performedwith stringent lysis andwash conditions
to selectively purify cross-linked RNA-protein complexes.
After immunoprecipitation, the association of AATF and
NGDN with pre-rRNA was investigated by RT-qPCR am-
plification of the 5′ETS pre-rRNA sequence. In the absence
of cross-linking, pre-rRNA is enriched in the AATF im-
munoprecipitation by ∼40-fold compared to the IgG con-
trol. However, after cross-linking there is a 315-fold en-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
proteins) InterPro domains for both lists. (B) A Venn diagram showing the overlap of this study, Pineiro (orange), with three other RNA interactome
capture studies – Baltz (blue), Beckmann (red) and Castello (yellow). (C) RNA interactome data were compared to nucleolar proteins from Andersen et al.
((21); ‘NOPdb’) and rRNA-processing proteins from Tafforeau et al ((2); ‘Tafforeau’). Of the proteins in our study that overlapped with either NOPdb or
Tafforeau, we further classified them into RNAPI-dependent (gray) or RNAPI-independent (gold/yellow). These counts are displayed as stacked barplots
for the two studies. (D) RNAPI-dependent and RNAPI-independent RBPs were annotated using Kyoto Encyclopaedia of Genes and Genomes (KEGG)
pathways (https://www.genome.jp/kegg/). Following annotation, an enrichment analysis was performed against a background of MCF10A proteins. The
size of the dot represents the fold enrichment over the background. The colour of the dot represents the significance of the enrichment (negative log2 of
the adjusted P-value) with grey being most significant and orange being the least. All terms displayed are significant and above the P-value cut-off of
0.05. See Supplementary Table S7 for a full list. (E) All proteins in the RNAPI-dependent and independent lists were mapped to Gene Ontology (GO)
terms (http://www.geneontology.org/). An enrichment for GO terms was performed against a background of the MCF10A proteome. The plot shows a
visualisation ofGOenrichment analysis for the proteins inRNAPI-dependent andRNAPI-independent lists. The numbers in brackets represent the number
of proteins in the input list that could be mapped to GO categories – 177/211 for RNAPI dependent and 225/246 for RNAPI-independent proteins. The
Y-axis shows the top GO categories represented in the dataset. The size and colour of dot represent fold enrichment and significance as in (D). Note that
all terms displayed are significant and above the P-value cut-off of 0.05. (F) A table showing a subset of proteins identified in the study that were chosen
for further experimental analysis ordered by RNAPI-dependent proteins (orange) in decreasing order of ActD/Ctrl ratio. Control RNAPI-independent,
(mRNA-binding proteins) are displayed in grey. Candidate RNAPI-dependent RBPs have a ratio of 0.35 or lower (>3-fold decrease in binding to RNA
when cells are treated with actinomycin D) in our mass spec analysis, whereas the control RBPs have a ratio close to 1.
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Figure 3. Subcellular distribution of AATF, TAP26, NOL10, IFI16, NGDN andKU70 in control and ActD or CX5461-treated cells. Immuno-localisation
of AATF (A), FLAG-tagged TAP26 (B), NOL10 (C), IFI16 (D), FLAG-taggedNGDN (E) and KU70 (F) in U-2 OS cells. Fibrillarin andHoechst staining
were used as nucleolar and nuclear markers respectively. The subcellular distribution of each protein was monitored in control cells and in cells treated
with actinomycin D (ActD) or CX5461. Each of the candidate RNAPI-dependent RBPs is present in the nucleolus. The size bar represents 10 microns.
richment of pre-rRNA in the AATF immunoprecipitation
(Figure 5B). These data indicate that we have selectively
enriched cross-linked RNA-protein complexes under these
conditions and that AATF interacts with the pre-rRNA.
In addition, under the same conditions we observed a 92-
fold enrichment of pre-rRNA after cross-linking immuno-
precipitation of NGDN (Figure 5C). Therefore, NGDN
also interacts with the pre-rRNA.We further confirmed the
specificity of the interaction of AATF and NGDN with
pre-rRNA by inhibiting the synthesis of pre-rRNA with
either ActD or CX5461 and performing cross-linking im-
munoprecipitationRT-qPCR.The abundance of pre-rRNA
in both AATF and NGDN cross-linked immunoprecipi-
tations decreased dramatically after inhibition of RNAPI,
confirming that AATF and NGDN specifically interact
with the pre-rRNA (Figure 5D and E). When combined
with our RNA interactome study, these data confirm that
AATF and NGDN are novel pre-rRNA binding proteins.
DISCUSSION
RNA interactome capture was originally developed to iden-
tify novel mRNA binding proteins (18), but importantly
our data show that it can also be used to identify RBPs
that associate with other RNA species. Thus, we demon-
strate that the same conditions that favour interaction be-
tween oligo(dT) and polyadenylated RNA also drive the
interaction of an abundant RNA, such as the pre-rRNA,
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Figure 4. Candidate RNAPI-dependent RBPs show reduced binding to RNA following inhibition of RNAPI. RNA interactome capture was performed in
cells treated with the RNAPI inhibitors ActD or CX5461 and in untreated cells. Samples were separated by SDS PAGE and subjected to western analysis
using antibodies against AATF and NOL10 (A), NGDN (B), IFI16 (C), TAP26 (D), KU70 (E) and KU80 (F). The data confirm that the recovery of
the candidate RNAPI-dependent RBPs decreases after RNAPI inhibition. Nucleolin (NCL) and nucleophosmin (NPM) were used as pre-rRNA binding
protein controls and PTB was used as an mRNA binding protein control.
with the captured polyadenylated RNA (Figure 1A, Sup-
plementary Figure S1). Therefore, we exploited this phe-
nomenon to define the RBPs that associate with RNAPI
RNA in the nucleus. We identified 211 RBPs with a >3-
fold difference in RNA binding following the selective inhi-
bition of RNAPI activity (Figures 1 and 2) and we have des-
ignated these RBPs as the RNAPI RNA interactome. Our
data have important implications for the interpretation of
the previously published RNA interactome capture exper-
iments. We suggest that these data cannot be regarded as
mRNA interactomes or even poly(A) RNA interactomes,
but that they should be considered to beRNA interactomes.
This conclusion is supported by analysis of the composite
list of humanRNA interactomes (6), which reveals that 87%
(183/211) of our RNAPI-dependent RBPs are present in
this list (SupplementaryTable S6). Furthermore, a compari-
son of the composite list with the nucleolar protein database
(NOPdbv2 (21)) reveals that 32% (442/1393) of these pro-
teins are nucleolar (Supplementary Table S7).
An alternative strategy to identifyRBPs associatedwith a
specific transcript is to use oligonucleotides-linked to beads
that target a defined RNA. For example, the recently de-
veloped method by Rogell et al., whereby proteins bound
to the target RNA are captured by hybridization with an-
tisense locked nucleic acid (LNA)/DNA oligonucleotides
covalently coupled to a magnetic resin (31). However, al-
though this technique was successfully employed to cap-
ture the RBPs bound to a reporter mRNA containing the
Sex-lethal (Sxl) binding motifs, when LNAs were directed
against 18S or 28S rRNAs very few ribosomal proteins were
obtained, with <30 proteins identified. As expected, there
is limited overlap between our data and the data of Rogell
et al., however, many of the ribosomal RNA binding pro-
teins identified byRogell et al.were classified by our work as
RNAPI independent (e.g. HNRNPs, YBX3, ELAV1), sug-
gesting that some of these interactions may not be rRNA
specific. The authors suggested that the dearth of riboso-
mal proteins identified was likely to be due to inefficient
crosslinking of proteins bound to double-stranded RNA,
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Figure 5. ANN complex RBPs AATF andNGDNbind to pre-rRNA. (A) AATFwas isolated fromU-2 OS nuclear extracts by immunoprecipitation using
a specific antibody. IgG was used as a negative control. Immunoprecipitations were performed from extracts prepared either with or without Benzonase
treatment. The immunoprecipitated proteins were separated by SDS PAGE and AATF, NGDN and NOL10 were detected by western analysis. The data
show that AATF forms a complex with NOL10 and NGDN, but that the presence of NGDN in the complex depends on nucleic acid. (B) AATF was im-
munoprecipitated from nuclear extracts prepared from untreated and formaldehyde cross-linked U-2 OS cells. In addition, control immunoprecipitations
using IgG were performed. Samples were subjected to western analysis to confirm the specific isolation of AATF. In parallel, RNA was isolated from im-
munoprecipitates and RT-qPCR was carried out using primers to detect rRNA precursors. The y-axis on the graph represents the average fold enrichment
of rRNA precursors containing the 5′ETS in the different conditions relative to the IgG control. Values are the mean ± SD of three independent experi-
ments. * (P < 0.05) denotes statistically significant differences in RNA levels. (C) Cross-linking RNA immunoprecipitation of NGDN using the NGDN
FLAG-tagged cell line. Immunoprecipitation was performed in control (–) and doxycycline-treated (+) cells using the FLAG antibody. Western analysis
and qRT-PCR analysis was carried out as described in (B). Y-axis values are the mean± SD of three independent experiments. * (P< 0.05) denotes statisti-
cally significant differences in RNA levels. (D) U-2 OS cells were treated with CX5461 (CX) or ActD (Act), followed by in vivo formaldehyde cross-linking.
AATF was immunoprecipitated and protein samples were subjected to western analysis. The RNA isolated from the AATF immunoprecipitations was
subjected to RT-qPCR with specific primers as described above. The data represent the mean ± SD of three independent experiments, **** (P < 0.0005).
(E) Cross-linking RIP was performed on cells treated as described above, using FLAG antibodies to isolate FLAG-tagged NGDN. Protein samples and
RNA samples were processed as described in (D). The data represent the mean ± SD of three independent experiments, **** (P < 0.0005).
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which involves much of the ribosomal RNA. Importantly,
our data show that the many interaction sites provided by
mRNA-rRNA contacts in the RIC technique are sufficient
to overcome such issues and the method that we use pro-
vides an accurate data set of the RBPs that interact with
rRNA.
RNAPI is known to generate two species of RNA, the
45S pre-rRNA and non-coding RNA derived from the in-
tergenic spacer region of rDNA (IGS rRNA) (32). IGS
rRNA are approximately 100-fold less abundant than pre-
rRNA (32), suggesting that the majority of the RNA-
protein interactions we observe in the RNAPI RNA inter-
actome involve pre-rRNA. Consistent with this interpreta-
tion, bioinformatic analysis reveals that terms associated
with ribosome biogenesis are significantly enriched in our
RNAPI-dependent RBPs (Figure 2) and ∼73% of these
proteins have previously been shown to influence ribosome
biogenesis (2,3). Thus, characterisation of theRNAPIRNA
interactome has provided a comprehensive record of the
RBPs that influence ribosome biogenesis, particularly those
involved in the processing of pre-rRNA. Furthermore, we
have now confirmed that AATF and NGDN, which have
been shown to play a role in facilitating cleavage of the pre-
rRNA within the 5′ETS and ITS1 (7), are novel pre-rRNA
binding proteins. While previous studies (7) suggested that
these proteins bind directly each other, our data suggest that
they also interact through an RNA intermediate. Further
investigation of these candidates using techniques such as
UV-crosslinking combined with immunoprecipitation and
sequencing could be used to define the sites of pre-rRNA
interaction.
Importantly, the RNAPI RNA interactome provides a
new tool to understand howRNA-protein interactions con-
trol ribosome biogenesis. These data are of considerable in-
terest since there are a number of disorders that are as-
sociated with dysregulated ribosome biogenesis. These in-
clude leukaemias (e.g. T-ALL, CLL), solids tumours (e.g.
colon, gastric) and a group of rare syndromes termed ri-
bosomopathies, many of which are associated with an in-
creased cancer risk ((33,34). Ribosome biogenesis has been
identified as a pathway that can be targeted in tumorigenesis
and small molecule inhibitors are currently under develop-
ment (e.g. CX5461 (27,28)). Thus, it is reasonable to pre-
dict that the RBPs required for ribosome biogenesis could
provide new therapeutic avenues to identify novel chemicals
that target this process.
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